1,560
Views
3
CrossRef citations to date
0
Altmetric
Research paper

Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells

, , , & ORCID Icon
Pages 9806-9818 | Received 17 Jul 2021, Accepted 15 Oct 2021, Published online: 02 Dec 2021

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
  • Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.
  • Fujioka H, Sakai A, Tanaka S, et al. Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines. Oncol Lett. 2017;13(1):289–295.
  • Brozik A, Hegedus C, Erdei Z, et al. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance? Expert Opin Drug Metab Toxicol. 2011;7(5):623–642.
  • Gerweck LE, Vijayappa S, Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther. 2006;5(5):1275–1279.
  • Liao R, Ma QZ, Zhou CY, et al. Identification of biomarkers related to tumor-infiltrating lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer. Bioengineered. 2021;12(1):1676–1688.
  • Hersey P, Zhang XD. Treatment combinations targeting apoptosis to improve immunotherapy of melanoma. Cancer Immunol Immunother. 2009;58(11):1749–1759.
  • Marchiq I, Pouysségur J. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters. J Mol Med. 2016;94(2):155–171.
  • Wang J, Shi W, Miao Y, et al. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered. 2021;12(1):6286–6304.
  • Silagi ES, Schipani E, Shapiro IM, et al. The role of HIF proteins in maintaining the metabolic health of the intervertebral disc. Nat Rev Rheumatol. 2021;17(7):426–439.
  • Damaghi M, Wojtkowiak JW, Gillies RJ. pH sensing and regulation in cancer. Front Physiol. 2013;4(370):370.
  • Kopecka JC, Ivana; Jacobs, Andrea; Frei, Andreas P.; Ghigo, Dario; Wollscheid, Bernd; Riganti, Chiara. Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells9 Oncotarget. 2015;6.
  • Yan J, Shi L, Lin S, et al. MicroRNA-624-mediated ARRDC3/YAP/HIF1alpha axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Bioengineered. 2021;12(1):5334–5347.
  • Comsa S, Cimpean AM, Raica M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 2015;35(6):3147–3154.
  • Barnett DH, Sheng S, Charn TH, et al. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res. 2008;68(9):3505–3515.
  • Berardo C, Siciliano V, Di Pasqua LG, et al. Comparison between lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma. Eur J Histochem. 2019 Aug 6;63(3):3048.
  • Shang Y, Jiang YL, Ye LJ, et al. Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells. Bioengineered. 2021;12(1):2253–2262.
  • Gao F, Wu H, Wang R, et al. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 2019;10(1):1–12.
  • Mohan S, Abdul AB, Abdelwahab SI, et al. Typhonium flagelliforme induces apoptosis in CEMss cells via activation of caspase-9, PARP cleavage and cytochrome c release: its activation coupled with G0/G1 phase cell cycle arrest. J Ethnopharmacol. 2010;131(3):592–600.
  • Uren RT, Iyer S, Kluck RM. Pore formation by dimeric Bak and Bax: an unusual pore? Philos Trans R Soc Lond B Biol Sci. 2017;372:1726.
  • Clatici VG, Voicu C, Voaides C, et al. Diseases of civilization - cancer, diabetes, obesity and acne - the implication of milk, IGF-1 and mTORC1. Maedica J Clin Med. 2018;13(4):273–281.
  • Wang Y, Zhang Y, Chi P, et al. Prediction of poor prognosis in breast cancer patients based on MicroRNA-21 expression: a meta-analysis. PLoS One. 2015;10(2):e0118647.
  • Khongkow P, Gomes AR, Gong C, et al. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene. 2016;35(8):990–1002.
  • Gong JP, Yang L, Tang JW, et al. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett. 2016;12(5):3905–3911.
  • Chi Y, Xue J, Huang S, et al. CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 2019;9(23):6840–6855.
  • Wang H, The V, Ali H, et al. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells. BMC Cancer. 2014;14(1):37.
  • Samaan TMA, Samec M, Liskova A, et al. Paclitaxel’s mechanistic and clinical effects on breast cancer. Biomolecules. 2019;9(12):789.
  • Waheed A, Sly WS. Carbonic anhydrase XII functions in health and disease. Gene. 2017Aug 5 ;623:33-40.
  • Watson PH, Chia SK, Wykoff CC, et al. Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer. 2003;88(7):1065–1070.
  • Yw L, Lei J, Zou W, et al. High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer. Neoplasma. 2019,66(3):420-426.
  • von Neubeck B, Gondi G, Riganti C, et al. An inhibitory antibody targeting Carbonic Anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. Int J Cancer. 2018,143(8):2065-2075.
  • Joanna K, Gregory M, Rankin I, et al. P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors. Oncotarget. 2016,7(52):85861-85875.
  • Chi X, Gatti P, Papoian T. Safety of antisense oligonucleotide and siRNA-based therapeutics. Drug Discov Today. 2017;22(5):823.
  • Ngamcherdtrakul W, Yantasee W. siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion. Transl Res. 2019,214:105-120.
  • Huan M, Wilson X, Mai H, et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. Acs Nano. 2013;7(2):994–1005.
  • Deng ZJ, Morton SW, Ben-Akiva E, et al. Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. Acs Nano. 2013;7(11):9571–9584.
  • Gong C, Hu C, Gu F, et al. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J Control Release. 2017;266:272–286.
  • Wang S, Liu X, Chen S, et al. Regulation of Ca2+ signaling for drug-resistant breast cancer therapy with mesoporous silica nanocapsule encapsulated doxorubicin/siRNA cocktail. Acs Nano. 2018;13:1.
  • Liu L, Zhang Z, Xing D. Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage. Free Radic Biol Med. 2011;51(1):53–68.
  • Peña‐Blanco A, García‐Sáez AJ. Bax, Bak and beyond: mitochondrial performance in apoptosis. FEBS J. 2017;285(3):416-431.
  • Willimott S, Merriam T, Wagner SD. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia. Biochem Biophys Res Commun. 2011;405(3):480–485.
  • Morciano G, Pedriali G, Sbano L, et al. Intersection of mitochondrial fission and fusion machinery with apoptotic pathways: role of Mcl-1. Biol Cell. 2016,108(10):279-293.
  • Roos WP. DNA damage-induced cell death by apoptosis. Trends Mol Med. 2006;12(9):440–450.
  • Wang XY, Wu KH, Pang HL, et al. Study on the role of cytc in response to BmNPV infection in silkworm, Bombyx mori (Lepidoptera). Int J Mol Sci. 2019;20(18):4325.
  • Jubin T, Kadam A, Jariwala M, et al. The PARP family: insights into functional aspects of poly (ADP‐ribose) polymerase‐1 in cell growth and survival. Cell Prolif. 2016;49(4):421–437.
  • Giannakakou P, Robey R, Fojo T, et al. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene. 2001;20(29):3806–3813.
  • Pan Z, Avila A, Gollahon L. Paclitaxel induces apoptosis in breast cancer cells through different calcium—regulating mechanisms depending on external calcium conditions. Int J Mol Sci. 2014;15(2):2672-2694.